Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line

Area of Science:

• Cancer Biology
• Cell Line Characterization
• Genomics and Transcriptomics

Background:

• Pancreatic cancer is a complex disease often characterized by significant intratumor heterogeneity.
• Understanding this heterogeneity is crucial for developing effective therapeutic strategies.
• The MIA PaCa-2 cell line is a commonly used model, but its heterogeneity requires detailed characterization.

Purpose of the Study:

• To evaluate the suitability of the MIA PaCa-2 cell line for investigating pancreatic cancer intratumor heterogeneity.
• To characterize the phenotypic, genomic, and transcriptomic heterogeneity within the MIA PaCa-2 cell line.

Main Methods:

• Establishment of MIA PaCa-2 single-cell clones using flow cytometry.
• Phenotypic analysis including morphology, proliferation, migration, and drug sensitivity.
• Genomic analysis via SNP array (SNPa) for copy number alterations and single nucleotide variations.
• Transcriptomic analysis using RNA-sequencing (RNA-seq) to assess gene expression profiles.

Main Results:

• Four distinct MIA PaCa-2 clones displayed varied phenotypes in morphology, proliferation, migration, and drug sensitivity.
• Genomic variations, including copy number and single nucleotide variations, were observed, indicating genomic instability.
• Transcriptomic analysis revealed differential gene expression, notably ITGAV, influencing clone morphology.

Conclusions:

• MIA PaCa-2 cells possess distinct phenotypes, heterogeneous genomes, and differential transcriptomic profiles.
• These characteristics support the suitability of MIA PaCa-2 as a model for studying pancreatic cancer heterogeneity mechanisms.
• Further research using this model can elucidate the underlying drivers of cancer heterogeneity.